REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 6 filers reported holding REGENERON PHARMACEUTICALS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,569 | -4.3% | 33,500 | -16.5% | 0.02% | -8.3% |
| Q2 2023 | $28,813 | -35.9% | 40,100 | -26.7% | 0.02% | -38.5% |
| Q1 2023 | $44,945 | +9.5% | 54,700 | -3.9% | 0.04% | -13.3% |
| Q4 2022 | $41,052 | -99.8% | 56,900 | +113.9% | 0.04% | +114.3% |
| Q3 2022 | $18,323,000 | +158.3% | 26,600 | +121.7% | 0.02% | +162.5% |
| Q2 2022 | $7,093,000 | +69.3% | 12,000 | +100.0% | 0.01% | +100.0% |
| Q1 2022 | $4,190,000 | -57.5% | 6,000 | -61.5% | 0.00% | -60.0% |
| Q4 2021 | $9,851,000 | -47.7% | 15,600 | -52.4% | 0.01% | -44.4% |
| Q3 2021 | $18,847,000 | +13.6% | 32,800 | +10.4% | 0.02% | +12.5% |
| Q2 2021 | $16,588,000 | – | 29,700 | +16041.3% | 0.02% | – |
| Q1 2021 | $0 | -100.0% | 184 | -55.6% | 0.00% | -100.0% |
| Q4 2020 | $20,000,000 | +188.1% | 414 | +233.9% | 0.03% | +188.9% |
| Q3 2020 | $6,941,000 | -33.8% | 124 | -26.2% | 0.01% | -47.1% |
| Q2 2020 | $10,477,000 | -70.8% | 168 | -77.1% | 0.02% | -73.0% |
| Q1 2020 | $35,840,000 | +25.3% | 734 | -3.7% | 0.06% | 0.0% |
| Q4 2019 | $28,611,000 | +62.2% | 762 | +19.8% | 0.06% | +26.0% |
| Q3 2019 | $17,642,000 | -18.3% | 636 | -7.8% | 0.05% | -15.3% |
| Q2 2019 | $21,597,000 | +86.5% | 690 | +144.7% | 0.06% | +84.4% |
| Q1 2019 | $11,579,000 | -25.8% | 282 | -32.5% | 0.03% | -30.4% |
| Q4 2018 | $15,612,000 | +25.5% | 418 | +35.7% | 0.05% | +15.0% |
| Q3 2018 | $12,444,000 | -6.8% | 308 | -20.4% | 0.04% | -23.1% |
| Q2 2018 | $13,351,000 | +334.0% | 387 | -95.2% | 0.05% | -61.5% |
| Q1 2018 | $3,076,000 | +625.5% | 8,138 | +622.1% | 0.14% | +650.0% |
| Q4 2017 | $424,000 | -77.4% | 1,127 | -5.9% | 0.02% | -76.6% |
| Q3 2017 | $1,874,000 | -49.7% | 1,198 | +12.1% | 0.08% | -52.5% |
| Q2 2017 | $3,726,000 | +175.2% | 1,069 | +22.2% | 0.16% | +174.6% |
| Q1 2017 | $1,354,000 | +464.2% | 875 | +9.2% | 0.06% | +321.4% |
| Q4 2016 | $240,000 | -42.6% | 801 | +39.3% | 0.01% | -50.0% |
| Q3 2016 | $418,000 | +102.9% | 575 | -17.0% | 0.03% | +100.0% |
| Q2 2016 | $206,000 | -10.0% | 693 | -1.8% | 0.01% | -22.2% |
| Q1 2016 | $229,000 | -69.8% | 706 | +159.6% | 0.02% | -69.5% |
| Q4 2015 | $758,000 | -29.9% | 272 | -52.0% | 0.06% | -25.3% |
| Q3 2015 | $1,081,000 | -6.6% | 567 | +111.6% | 0.08% | -18.6% |
| Q2 2015 | $1,157,000 | +96.1% | 268 | -2.9% | 0.10% | +40.6% |
| Q1 2015 | $590,000 | -78.4% | 276 | -49.7% | 0.07% | -79.2% |
| Q4 2014 | $2,734,000 | – | 549 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Garda Capital Partners LP | 3,500 | $2,880,360 | 0.13% |
| GROUP ONE TRADING, L.P. | 31,900 | $26,252,424 | 0.09% |
| SIMPLEX TRADING, LLC | 33,500 | $27,569 | 0.02% |
| IMC-Chicago, LLC | 26,500 | $21,808,440 | 0.02% |
| Allianz Asset Management GmbH | 12,400 | $10,204,704 | 0.02% |
| SG Americas Securities, LLC | 16,700 | $1,142 | 0.01% |
| JANE STREET GROUP, LLC | 42,400 | $34,893,504 | 0.01% |
| JPMORGAN CHASE & CO | 32,900 | $27,075,384 | 0.00% |
| Focused Wealth Management, Inc | 400 | $12,441 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |